Petros Pharmaceuticals Inc (NAS:PTPI)
$ 0.61 -0.0035 (-0.57%) Market Cap: 4.27 Mil Enterprise Value: 2.11 Mil PE Ratio: 0 PB Ratio: 0.43 GF Score: 44/100

Petros Pharmaceuticals Inc at Benzinga Global Small Cap Investor Conference (Virtual) Transcript

Dec 10, 2021 / NTS GMT
Release Date Price: $27 (+14.41%)
Spencer Israel
Benzinga - Moderator

As we have entered what I'm going to refer to as he -- how I do I want to put this, like the high flying part of the day, for whatever reason, a lot of the companies that we've had people clamoring for are all bunched up together. We've had a few people on that chat asking about our next speaker actually Petros Pharma. And I do see Fady Boctor here. He's the President and CCO. So let's bring Fady on right now. There he is. Fady, how we doing today?

Fady Boctor
Petros Pharmaceuticals, Inc. - President & CCO

Doing well, Spencer. How are you?

Spencer Israel
Benzinga - Moderator

Doing great. You're a little quiet, so just try to speak up if you can. Do we Fady's slides, guys? Yes, we do. There they are. All right. Just try to speak up, Fady. And the floor is yours.

Fady Boctor
Petros Pharmaceuticals, Inc. - President & CCO

You got it. Let me know if this doesn't come through. I tend to have a lower voice. But let's dive right in.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot